Literature DB >> 6302648

Primary hepatocellular carcinoma arising in a renal transplant recipient with polycystic disease.

B P Gardner, D B Evans.   

Abstract

Malignant disease arises more commonly in renal transplant recipients than in non-transplanted individuals. Renal polycystic disease is the only cause of renal failure that has a statistically significant association with the acquisition of malignancy in renal transplant recipients. This patient, who had renal failure due to polycystic disease, is the first reported renal transplant recipient to develop a hepatocellular carcinoma in an otherwise completely normal liver. It is suggested that patients with polycystic renal disease may have an unidentified factor that predisposes to the development of malignancy in them after transplantation.

Entities:  

Mesh:

Year:  1983        PMID: 6302648      PMCID: PMC2417379          DOI: 10.1136/pgmj.59.688.120

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  6 in total

1.  Hepatocarcinoma and myocardial fibrosis in an 8 and three-fourths year-old renal transplant recipient.

Authors:  G S Arbus; R H Hung
Journal:  Can Med Assoc J       Date:  1972-09-09       Impact factor: 8.262

2.  Neoplasia in renal transplant recipients.

Authors:  K Pritzker
Journal:  Can Med Assoc J       Date:  1972-12-09       Impact factor: 8.262

3.  Immunosuppression and cancer.

Authors:  A Myking
Journal:  Lancet       Date:  1969-04-05       Impact factor: 79.321

4.  Immunosuppression and cancer.

Authors:  I Penn; T E Starzl
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

5.  Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

Authors:  R Y Calne; K Rolles; D J White; S Thiru; D B Evans; P McMaster; D C Dunn; G N Craddock; R G Henderson; S Aziz; P Lewis
Journal:  Lancet       Date:  1979-11-17       Impact factor: 79.321

6.  Chronic antigenic stimulation, herpesvirus infection, and cancer in transplant recipients.

Authors:  A J Matas; R L Simmons; J S Najarian
Journal:  Lancet       Date:  1975-06-07       Impact factor: 79.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.